Trials / Completed
CompletedNCT07158333
Mobile Cardiac Telemetry (MCT) Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study will be a single center, single arm, open-label, prospective study to evaluate adhesive performance of the Bardy Diagnostics' (BardyDx) MCT Patch up to 30 days of wear.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mobile Cardiac Telemetry (MCT System) | MCT System without data transmission |
Timeline
- Start date
- 2025-08-05
- Primary completion
- 2025-09-12
- Completion
- 2025-09-12
- First posted
- 2025-09-05
- Last updated
- 2025-11-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07158333. Inclusion in this directory is not an endorsement.